BiotechTube
Home/Accro Bioscience/Ki Rito
KR

Ki Rito

Chief Medical Officer

Accro Bioscience

Therapeutic Areas

OncologyImmunology

Accro Bioscience Pipeline

DrugIndicationPhase
AC-201Moderate-to-Severe Plaque PsoriasisPhase 2
AC-101Ulcerative Colitis / Inflammatory Bowel DiseasePhase 1b
AC-003Acute Graft-Versus-Host Disease (aGVHD)Phase 1b

Leadership Team at Accro Bioscience

X(
Xiaohu (Jason) Zhang, Ph.D.
Co-founder & CEO
SH
Sudan He, Ph.D.
Co-founder & Chief Scientific Advisor
KG
Kenneth Gao
SVP, Corporate Development & Strategy
View full Accro Bioscience profile